Back to Screener

Healthcare

Shandong Weigao Group Medical Polymer Company Limited(SHWGY)

Live Price

Offline

$1.70

+6.92% today

1Y Change

-37.28%

Window

Jun 23, 2025 โ†’ Jun 15, 2026

Market Cap
$13.36B
Revenue Growth
-0.5%
EPS Growth
-23.9%
Dividend Yield
7.0%

Coverage: 247 bars ยท Jun 23, 2025 โ†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Shandong Weigao Group Medical Polymer Company Limited (SHWGY) is a Healthcare stock with a market cap of $13.36B and listed on OTC. The stock last traded around $1.70 and down 37.3% across the available one-year price window (Jun 23, 2025 โ†’ Jun 15, 2026). Baseline metrics include revenue growth of -0.5%, EPS growth of -23.9%, a dividend yield of 7.0%. What stands out right now is revenue -0.5%, EPS -23.9%, free cash flow -19.8% with operating margin 14.1% and ROIC 4.9%. The dividend matters to the case here, with a current yield around 7.0%. Valuation is more restrained than many high-expectation growth names at P/E 8.4 and price/sales 1.0. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SHWGY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-0.5% vs +7.6% peer median

Operating Margin

Below sector median

+14.1% vs +19.4% peer median

P/E

Below sector median

8.4 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on Mar 24, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -0.5% and EPS is at -23.9%, with operating margin around 14.1%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 7.0%, which matters if the thesis depends on income as much as growth.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -2.9% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Mar 24, 2026
โ€”-5.8%-8.8%-32.5%
2025
Sep 1, 2025
โ€”+0.0%+0.0%-15.9%
2025
Mar 24, 2025
โ€”+0.0%+0.0%+16.5%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SHWGY

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SHWGY Max Drawdown

-54.42%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SHWGY and SPY.

Calendar-year return history is still loading or unavailable.
Shandong Weigao Group Medical Polymer Company Limited logo

Company Overview

Shandong Weigao Group Medical Polymer Company Limited

Other OTC

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Leadership
Rinan Cong
IPO Date
Apr 18, 2012
Employees
12.7k
Street Address
Torch Hi-Tech Science Park
Mailing
Weihai, 264210
Region
Weihai, CN
Reporting Currency
USD
Investor Line
86 63 1562 1999
Last Updated
May 4, 2026
ISIN: US81941W1018
ADR ListedReports in USD

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
8.4
EV/EBITDA
3.7
Price/Sales
1.0
Price/Book
0.6

Growth

Revenue
-0.5%
EPS
-23.9%
Free Cash Flow
-19.8%

Profitability

Gross Margin
46.6%
Operating Margin
14.1%
Net Margin
12.1%
ROE
6.6%
ROIC
4.9%

Balance Sheet

Debt/Equity
0.25
Current Ratio
3.78

Earnings Reports

๐Ÿ“… Last reportedMar 24, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Mar 24, 26
0.07
Est โ€”
โ€”
946431.8B
Est โ€”
โ€”
โ€”
Sep 1, 25
0.12
Est โ€”
โ€”
926512.5B
Est โ€”
โ€”
โ€”
Mar 24, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 24
0.12
Est โ€”
โ€”
883581.4B
Est โ€”
โ€”
โ€”
Aug 28, 24
0.13
Est โ€”
โ€”
913137.0B
Est โ€”
โ€”
โ€”
May 28, 24
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 23
0.10
Est โ€”
โ€”
893998.3B
Est โ€”
โ€”
โ€”
Jun 30, 23
0.15
Est โ€”
โ€”
952055.0B
Est โ€”
โ€”
โ€”
Dec 31, 22
0.16
Est โ€”
โ€”
974020.4B
Est โ€”
โ€”
โ€”
Jun 30, 22
0.20
Est โ€”
โ€”
1056187.6B
Est โ€”
โ€”
โ€”
Dec 31, 21
0.15
Est โ€”
โ€”
1095937.5B
Est โ€”
โ€”
โ€”
Jun 30, 21
0.17
Est โ€”
โ€”
963273.3B
Est โ€”
โ€”
โ€”
Dec 31, 20
0.15
Est โ€”
โ€”
981462.0B
Est โ€”
โ€”
โ€”
Jun 30, 20
0.13
Est โ€”
โ€”
738663.8B
Est โ€”
โ€”
โ€”
Dec 31, 19
0.12
Est โ€”
โ€”
789299.6B
Est โ€”
โ€”
โ€”
Jun 30, 19
0.12
Est โ€”
โ€”
719354.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.